156 related articles for article (PubMed ID: 22102064)
1. CD99 is expressed in chordoid glioma and suggests ependymal origin.
Romero-Rojas AE; Díaz-Pérez JA; Ariza-Serrano LM
Virchows Arch; 2012 Jan; 460(1):119-22. PubMed ID: 22102064
[No Abstract] [Full Text] [Related]
2. Immunohistochemical and ultrastructural study of chordoid glioma of the third ventricle: its tanycytic differentiation.
Sato K; Kubota T; Ishida M; Yoshida K; Takeuchi H; Handa Y
Acta Neuropathol; 2003 Aug; 106(2):176-80. PubMed ID: 12748871
[TBL] [Abstract][Full Text] [Related]
3. Chordoid glioma of the third ventricle: a report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature.
Pasquier B; Péoc'h M; Morrison AL; Gay E; Pasquier D; Grand S; Sindou M; Kopp N
Am J Surg Pathol; 2002 Oct; 26(10):1330-42. PubMed ID: 12360048
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation?
Lehman NL
J Neuropathol Exp Neurol; 2008 Mar; 67(3):177-88. PubMed ID: 18344909
[TBL] [Abstract][Full Text] [Related]
5. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
6. PNETs everywhere.
Sur M; Cooper K
Histopathology; 1999 Sep; 35(3):279-80. PubMed ID: 10469221
[No Abstract] [Full Text] [Related]
7. Utility of immunohistochemistry for CD99 in the identification of matrix-producing carcinoma of the breast.
Walker JA; Carder PJ
Histopathology; 2003 Mar; 42(3):300-1. PubMed ID: 12605650
[No Abstract] [Full Text] [Related]
8. Chordoid glioma: report of two rare examples with unusual features.
Jain D; Sharma MC; Sarkar C; Suri V; Rishi A; Garg A; Vaishya S
Acta Neurochir (Wien); 2008 Mar; 150(3):295-300; discussion 300. PubMed ID: 18246456
[TBL] [Abstract][Full Text] [Related]
9. Origin of chordoid glioma of the third ventricle.
Leeds NE; Lang FF; Ribalta T; Sawaya R; Fuller GN
Arch Pathol Lab Med; 2006 Apr; 130(4):460-4. PubMed ID: 16594739
[TBL] [Abstract][Full Text] [Related]
10. Chordoid Glioma with Intraventricular Dissemination: A Case Report with Perfusion MR Imaging Features.
Ki SY; Kim SK; Heo TW; Baek BH; Kim HS; Yoon W
Korean J Radiol; 2016; 17(1):142-6. PubMed ID: 26798226
[TBL] [Abstract][Full Text] [Related]
11. Chordoid glioma of the third ventricle: four cases including one case with papillary features.
Ni HC; Piao YS; Lu DH; Fu YJ; Ma XL; Zhang XJ
Neuropathology; 2013 Apr; 33(2):134-9. PubMed ID: 22716306
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approach to chordoid glioma of the third ventricle.
Kobayashi T; Tsugawa T; Hashizume C; Arita N; Hatano H; Iwami K; Nakazato Y; Mori Y
Neurol Med Chir (Tokyo); 2013; 53(4):249-55. PubMed ID: 23615418
[TBL] [Abstract][Full Text] [Related]
13. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
Nicholson SA; McDermott MB; Swanson PE; Wick MR
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
[TBL] [Abstract][Full Text] [Related]
14. Chordoid glioma: a novel tumor of the third ventricle.
Castellano-Sanchez AA; Recine MA; Restrepo R; Howard LH; Robinson MJ
Ann Diagn Pathol; 2000 Dec; 4(6):373-8. PubMed ID: 11149969
[TBL] [Abstract][Full Text] [Related]
15. An incidentally detected third ventricle chordoid glioma.
Gallina P; Pansini G; Mouchaty H; Mura R; Buccoliero AM; Di Lorenzo N
Neurol India; 2007; 55(4):406-7. PubMed ID: 18040120
[TBL] [Abstract][Full Text] [Related]
16. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
[TBL] [Abstract][Full Text] [Related]
17. The radiological findings of chordoid glioma: report of two cases, one case with MR spectroscopy.
Qixing F; Peiyi G; Kai W; Xuzhu C; Xiangde M; Jianping D
Clin Imaging; 2015; 39(6):1086-9. PubMed ID: 26275847
[TBL] [Abstract][Full Text] [Related]
18. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
19. Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.
Matias-Guiu X; Pons C; Prat J
Hum Pathol; 1998 Aug; 29(8):840-5. PubMed ID: 9712426
[TBL] [Abstract][Full Text] [Related]
20. Chordoid glioma of the third ventricle: Report of a case with cytologic features and utility during intraoperative consultation.
Takei H; Bhattacharjee MB; Adesina AM
Acta Cytol; 2006; 50(6):691-6. PubMed ID: 17152286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
